Breast Cancer and Sexuality
Breast Cancer and Sexuality
Breast Cancer and Sexuality
According the 2021 reports of the WHO – World Health Organization, there were 7.8 million
women alive who were diagnosed with breast cancer in the past 5 years, making it the world's most
prevalent cancer. The increasing number of breast cancer survivors has led to a greater emphasis on
issues related to quality of life (QoL). Up to 75% of women treated for breast cancer report sexual
disorders. Treatment of early breast cancer relies on the combination of chemotherapy, surgery, and
radiation therapy. All these treatments, beyond the cancer itself, have side effects or sequelae
identified as high-risk factors for the development of female sexual dysfunctions. Despite these
data, conversations about the consequences on sexuality are not happening often between
cancer patients and healthcare providers. Often healthcare providers wait for the patients to
bring up the topic and the patients tend to avoid it for discomfort or to bring it up only if it is of the
uttermost importance in the short period. But if we take an example: in a recent study it was found
that unpartnered women reported themselves to be sexually inactive, and perhaps for this reason,
they seemed relatively more likely to speak about concerns about body image rather than sexual
function concerns. But this also means that if they do find a partner meanwhile, they are not
informed about or prepared for the consequences they might encounter in sexual function.
So what should doctor bear in mind when having a conversation with breast cancer patients?
First of all it’s important to view the treatments not only from a medical perspective, but from that
of the patient. For example, the conversations shouldn’t be only about informed consent for
surgeries. These type of conversations do not necessarily include a great deal of depth
concerning what these changes would mean in terms of the daily impact or coping with the
changes. The treatments of breast cancer have particular consequences for the female body, which
can directly influence a woman’s self-esteem, appearance and sexual desire. For example after
chemotherapy and hormone therapy important adverse effects are present in terms of vaginal
dryness, dysparunia and sexual well-being. For what concerns mastectomy, losing the breast seems
to be the only choice for women with breast cancer to be declared cancer-free. While “losing their
breast” could give a sense of security and happiness for a second chance to live, it could also impact
the identity as a woman because of the disfigured body appearance. Women feel “less feminine”,
they don’t feel enough in respect to an inner ideal standard, thus leading to not feel enough for the
partner and avoiding sexual intimacy. In turn, this could discourage the partner in searching further
intimate contacts, making the woman feel less desired and leading to a vicious cycle. Discussions
about the sensitivity after surgery are also important.
The choice of less toxic treatments in each modality could reduce the risk of female sexual
dysfunctions in some cases, without affecting the risk of recurrence or effectiveness.
Most women prefer to receive information about the impact on intimacy and sexuality from a
nurse or primary doctor. The preferred method of communication is a conversation with a
professional together with their partner or a personal conversation with a professional,
supported by a brochure or website.
Timing in which the information is given is also important. Intimacy and sexuality should be
repeatedly included in consultations, at every stage of the disease but especially shortly after the
treatment started.
There might be barriers that could limit dialogue between patients and healthcare providers .
One of the strongest barriers tend to be owning negative beliefs about discussing sexual concerns,
such as “sexual dysfunctions are of lower priority”. Also, leaving the topic at the end of the
discussion and with shorter time might make the patient feel as if it is effectively of lower
importance and not leave the proper time to go deeper.
Another negative belief held by healthcare providers is that “patients don’t want to talk about it”.
According to this opinion raising sexual concerns with patients who are uncomfortable could have
detrimental effects on the patient-provider relationship. In this case there are factors mediating the
possible discomfort as the trust in the patient-provider relationship, the perception that the
expressions of sexual concerns would be well received by their providers and positive prior
experiences in discussing sexual concerns that could lead the patient to feel secure to bring it up
again. Once the provider has raised the discussion, to not push the patient, it could be up to her to
decide on the path of speech.
Time and privacy could also be constraints. It should be made sure that sexual difficulties are
discussed in a private room and with proper time as for any other information that is given to the
patient.
Being aware of communication dynamics and limitations is of fundamental importance when one
has to deliver information on and deal with a sensitive topic such as sexuality and will serve as a
basis to develop further and specific interventions.
- Albers L. F., Van Ek G. F., Krouwel E. M., Oosterkamp-Borgelink C. M., Liefers G. J., Den
Ouden M. E. M., Den Oudsten B. L., Krol-Warmerdam E. E. M.,Guicherit O. R.,Linthorst-Niers
E., Putter H., Pelger R. C. M. & Elzevier H. W. (2020). Sexual Health Needs: How Do Breast
Cancer Patients and Their Partners Want Information?, Journal of Sex & Marital Therapy, 46:3,
205-226, DOI: 10.1080/0092623X.2019.1676853
- Assad H., Badhwar G., Bhama S., Vakhariya C., Goodman J. R., (2014). Impact of breast cancer
diagnosis and treatment on sexual dysfunction. Journal of Clinical Oncology. 32:26_suppl, 125-125
- Barsky, R. J., Beach, M. C., Smith, K. C., Bantug, E. T., Casale, K. E., Porter, L. S., Bober, S. L.,
Tulsky, J. A., Daly, M. B., & Lepore, S. J. (2017). Effective patient-provider communication about
sexual concerns in breast cancer: a qualitative study. Support Care Cancer. doi:10.1007/s00520-
017-3729-1
- Den Ouden, M.E.M., Pelgrum-Keurhorst, M.N., Uitdehaag, M.J. et al., (2019). Intimacy and
sexuality in women with breast cancer: professional guidance needed. Breast Cancer. 26, 326–332.
doi:10.1007/s12282-018-0927-8
- Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL. (2016).
American Cancer Society/American society of clinical oncology breast cancer survivorship care
guideline. CA: A Cancer J Clin. 66. doi:10.3322/caac.21319
- Streicher L, Simon JA. (2018). Sexual function post-breast cancer. Cancer treatment and research.
Springer Cham Copyright Information: Springer International Publishing AG. Doi:10.1007/978-3-
319-70197-4_11